Aizawa Y, Izumita R, Saitoh A. Human parechovirus type 3 infection: An emerging infection in neonates and young infants. J Infect Chemother. 2017;23:419–26.
Harvala H, Robertson I, Chieochansin T, McWilliam Leitch EC, Templeton K, Simmonds P. Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis. 2009;199:1753–60.
Article CAS PubMed Google Scholar
Wigand R, Sabin AB. Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch. 1961;11:224–47.
Article CAS PubMed Google Scholar
Hyypia T, Horsnell C, Maaronen M, Khan M, Kalkkinen N, Auvinen P, et al. A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A. 1992;89:8847–51.
Article CAS PubMed PubMed Central Google Scholar
Ghazi F, Hughes PJ, Hyypiä T, Stanway G. Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol. 1998;79(Pt 11):2641–50.
Article CAS PubMed Google Scholar
Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J Gen Virol. 2004;85:391–8.
Article CAS PubMed Google Scholar
Boivin G, Abed Y, Boucher FD. Human parechovirus 3 and neonatal infections. Emerg Infect Dis. 2005;11:103–5.
Article PubMed PubMed Central Google Scholar
Schuffenecker I, Javouhey E, Gillet Y, Kugener B, Billaud G, Floret D, et al. Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol. 2012;54:337–41.
Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J. 2011;30:238–42.
Renaud C, Kuypers J, Ficken E, Cent A, Corey L, Englund JA. Introduction of a novel parechovirus RT-PCR clinical test in a regional medical center. J Clin Virol. 2011;51:50–3.
Walters B, Penaranda S, Nix WA, Oberste MS, Todd KM, Katz BZ, et al. Detection of human parechovirus (HPeV)-3 in spinal fluid specimens from pediatric patients in the Chicago area. J Clin Virol. 2011;52:187–91.
Article CAS PubMed Google Scholar
Felsenstein S, Yang S, Eubanks N, Sobrera E, Grimm JP, Aldrovandi G. Human parechovirus central nervous system infections in southern California children. Pediatr Infect Dis J. 2014;33:e87–91.
Midgley CM, Jackson MA, Selvarangan R, Franklin P, Holzschuh EL, Lloyd J, et al. Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014. J Pediatric Infect Dis Soc. 2018;7:104–12.
Sasidharan A, Banerjee D, Harrison CJ, Selvarangan R. Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016. J Clin Microbiol. 2021;59.
Lee BR, Sasidharan A, Harrison CJ, Selvarangan R. Disruption of seasonal enterovirus and parechovirus detections in the CSF and plasma of children during the COVID-19 pandemic. J Clin Virol. 2023;160:105381. A recent study demonstrating an impact of COVID-19 on the detection of enterovirus and parechovirus from children in the US.
Tao L, Humphries RM, Banerjee R, Gaston DC. Re-emergence of Parechovirus: 2017-2022 National Trends of Detection in Cerebrospinal Fluid. Open Forum Infect Dis. 2023;10:ofad112. A recent study demonstrating reemergence of parechovirus in CSF detected by multiplex PCR in the US.
Harvala H, McLeish N, Kondracka J, McIntyre CL, McWilliam Leitch EC, Templeton K, et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol. 2011;83:889–96.
Skram MK, Skanke LH, Krokstad S, Nordbo SA, Nietsch L, Dollner H. Severe parechovirus infection in Norwegian infants. Pediatr Infect Dis J. 2014;33:1222–5.
de Jong EP, van den Beuken MGA, van Elzakker EPM, Wolthers KC, Sprij AJ, Lopriore E, et al. Epidemiology of Sepsis-like Illness in Young Infants: Major Role of Enterovirus and Human Parechovirus. Pediatr Infect Dis J. 2018;37:113–8.
Cabrerizo M, Díaz-Cerio M, Muñoz-Almagro C, Rabella N, Tarragó D, Romero MP, et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. J Med Virol. 2017;89:435–42.
Article CAS PubMed Google Scholar
Linhares MI, Brett A, Correia L, Pereira H, Correia C, Oleastro M, et al. Parechovirus Genotype 3 Outbreak Among Young Infants in Portugal. Acta Med Port. 2021;34:664–8.
Elling R, Böttcher S, du Bois F, Müller A, Prifert C, Weissbrich B, et al. Epidemiology of Human Parechovirus Type 3 Upsurge in 2 Hospitals, Freiburg, Germany, 2018. Emerg Infect Dis. 2019;25:1384–8.
Article PubMed PubMed Central Google Scholar
Han TH, Chung JY, You SJ, Youn JL, Shim GH. Human parechovirus-3 infection in children. South Korea. J Clin Virol. 2013;58:194–9.
Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3. Emerg Infect Dis. 2015;21:1966–72.
Article CAS PubMed PubMed Central Google Scholar
Cumming G, Khatami A, McMullan BJ, Musto J, Leung K, Nguyen O, et al. Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013-2014. Emerg Infect Dis. 2015;21:1144–52.
Article CAS PubMed PubMed Central Google Scholar
Nelson TM, Vuillermin P, Hodge J, Druce J, Williams DT, Jasrotia R, et al. An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3. Sci Rep. 2017;7:44423.
Article CAS PubMed PubMed Central Google Scholar
Bialasiewicz S, May M, Tozer S, Day R, Bernard A, Zaugg J, et al. Novel Human Parechovirus 3 Diversity, Recombination, and Clinical Impact Across 7 Years: An Australian Story. J Infect Dis. 2023;227:278–87.
van der Sanden S, de Bruin E, Vennema H, Swanink C, Koopmans M, van der Avoort H. Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol. 2008;46:2884–9.
Article PubMed PubMed Central Google Scholar
Watanabe K, Hirokawa C, Tazawa T. Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan. Epidemiol Infect. 2016;144:3451–60.
Article CAS PubMed Google Scholar
Aizawa Y, Kasamatsu T, Nagasawa K, Watanabe K, Saitoh A. Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997-2019. J Infect Dis. 2023;227:288-294. A recent study demonstrating molecular evolution and epidemiology of PeV-A3 in Japan for the last 2 decades.
Tao L, Fill MA, Banerjee R, Humphries RM. Notes from the Field: Cluster of Parechovirus Central Nervous System Infections in Young Infants - Tennessee, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:977–8.
Article PubMed PubMed Central Google Scholar
Olijve L, Jennings L, Walls T. Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants. Clin Microbiol Rev. 2018;31.
Sharp J, Bell J, Harrison CJ, Nix WA, Oberste MS, Selvarangan R. Human parechovirus in respiratory specimens from children in Kansas City, Missouri. J Clin Microbiol. 2012;50(12):4111–3.
Article PubMed PubMed Central Google Scholar
Izumita R, Deuchi K, Aizawa Y, et al. Intrafamilial transmission of parechovirus A and enteroviruses in neonates and young infants. J Pediatric Infect Dis Soc. 2019;8(6):501–6.
Westerhuis BM, Jonker SC, Mattao S, Benschop KS, Wolthers KC. Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR. Virol J. 2013;10:146.
Article CAS PubMed PubMed Central Google Scholar
Klatte JM, Harrison CJ, Pate B, Queen MA, Neuhart J, Jackson MA, et al. Maternal parechovirus A (PeV-A) shedding, serostatus, and the risk of central nervous system PeV-A infections in infants. J Clin Virol. 2021;142:104939.
Karelehto E, Wildenbeest JG, Benschop KSM, Koen G, Rebers S, Bouma-de Jongh S, et al. Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease. Pediatr Infect Dis J. 2018;37:1304–8.
Article PubMed PubMed Central Google Scholar
Tanaka S, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Matsuzaki Y, et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol. 2016;60:854–8.
Article CAS PubMed Google Scholar
Karelehto E, Brouwer L, Benschop K, Kok J, Basile K, McMullan B, et al. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis. 2019;25:148–52.
Article CAS PubMed PubMed Central Google Scholar
Shimizu H, Hashimoto K, Sato M, Sato A, Maeda H, Kyozuka H, et al. Association Between Neutralizing Antibody Titers against Parechovirus A3 in Maternal and Cord Blood Pairs and Perinatal Factors. J Pediatric Infect Dis Soc. 2020;9:320–5.
留言 (0)